Wordt geladen...

Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia

Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood
Hoofdauteurs: Hasserjian, Robert P., Steensma, David P., Graubert, Timothy A., Ebert, Benjamin L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2020
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/
https://ncbi.nlm.nih.gov/pubmed/32232484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!